MoneyWorks4Me

Zydus Lifesciences informs about press release

09 Jun 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated June 9, 2023 titled ‘Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in Non-Alcoholic Fatty Liver Disease (NAFLD) patients with comorbidities.’

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..